Symposia: Aggressive Lymphomas: Cellular Therapies
	
	
	Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Lymphomas, Non-Hodgkin lymphoma, Assays, Elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Clinical Research, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Immunotherapy, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Registries, Technology and Procedures, Study Population, Radiation Therapy, Human, Measurable Residual Disease
	Type: Poster
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Lymphomas, Non-Hodgkin lymphoma, Assays, Elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Clinical Research, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Immunotherapy, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Registries, Technology and Procedures, Study Population, Radiation Therapy, Human, Measurable Residual Disease
Sunday, December 8, 2024: 6:00 PM-8:00 PM
	Halls G-H 
		(San Diego Convention Center)
	
	
	
	
	     
	
		
				
	
	
	
	
	
	
	See more of: Oral and Poster Abstracts
	
	
	
	
	*signifies non-member of ASH
					 
	
	 denotes an abstract that is clinically relevant.
 denotes an abstract that is clinically relevant. denotes that this is a recommended PHD Trainee Session.
 denotes that this is a recommended PHD Trainee Session. denotes that this is a ticketed session.
 denotes that this is a ticketed session.